scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on optimizing infused therapy delivery, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on optimizing infused therapy delivery, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024. The company's management will host a conference call and audio webcast at 4:30 p.m. ET to discuss the financial results and provide a business update.
Participants can join the call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259. A new Call me™ feature is available to avoid operator wait times. The live webcast and replay can be accessed through the company's website under the Investor Relations section.
Details
News Market Reaction – SCPH
The recorded move for SCPH in the trading session of this news was -3.99%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management to host conference call and webcast at 4:30 p.m. ET
BURLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, August 14, 2024, to discuss the financial results for the second quarter 2024 and provide a business update.
Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259.
To access the new Call me™ feature, which avoids having to wait for an operator, click here.
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.